… biomarker for evaluation of disease progression and early diagnosis of PD. Project Description :  In a previous study, … fMRI method on (1) 60 PD patients at different stage (from early to late stage), at both off and on levodopa …

… This grant builds upon the research from a prior grant: New Imaging Agents for … shown that at least two of these compounds can safely go into the living brain. When tagged with a special label to … of a suitable alpha-synuclein PET tracer would allow for early diagnosis of Parkinson’s disease. In addition, it …

… how one person will progress with PD, the results may help researchers design smaller, faster and less expensive clinical trials of new treatments. Changes in Early Parkinson's and with Dopamine Therapy The Parkinson's … of Denali Therapeutics, which brought the first LRRK2 drug into clinical trials late last year , told research news …

… in epidemiology at the University of Bergen in Norway. Her research is dedicated to identifying biomarkers, early signs, and risk factors of the onset and progression … prodromal phase of PD that poses an opportunity for early diagnosis and intervention. Dr. Cortese has extensive …

… wide experience in the field of neurodegenerative disease research, and her activity includes clinical … is in the field of cerebrospinal fluid biomarkers for early diagnosis of neurodegenerative diseases, with special …

… with the Foundation’s commitment to keep highly promising research moving forward as efficiently as possible, four of … Anders Lonneborg, PhD, will explore gene expression as an early detector of Parkinson’s, building on exciting … of PD patients that hold potential to be further developed into a simple blood test for Parkinson’s. The new project …